Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies
Top Cited Papers
Open Access
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 9 (9) , 543-558
- https://doi.org/10.1016/s1083-8791(03)00287-8
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood productsBlood, 2003
- Improved Monitoring of Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation by an Ultrasensitive Plasma DNA PCR AssayJournal of Clinical Microbiology, 2002
- β‐Herpesvirus Challenges in the Transplant RecipientThe Journal of Infectious Diseases, 2002
- Influence of Cytomegalovirus Seropositivity on Outcome after T Cell–Depleted Bone Marrow Transplantation: Contrasting Results between Recipients of Grafts from Related and Unrelated DonorsClinical Infectious Diseases, 2002
- Susceptibilities of Human Cytomegalovirus Clinical Isolates to BAY38-4766, BAY43-9695, and GanciclovirAntimicrobial Agents and Chemotherapy, 2001
- Virological, Clinical, and Ophthalmologic Features of Cytomegalovirus Retinitis after Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2001
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Pharmacokinetics of Valganciclovir and Ganciclovir Following Multiple Oral Dosages of Valganciclovir in HIV- and CMV-Seropositive VolunteersClinical Pharmacokinetics, 1999
- Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1998
- No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipientsBone Marrow Transplantation, 1997